{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:48:01Z","timestamp":1757616481060,"version":"3.44.0"},"reference-count":35,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2009,2,11]]},"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The Oxford-Family Planning Association (Oxford-FPA) contraceptive study has provided information on many serious diseases of the female reproductive tract. No information has been published about a number of common minor conditions. This report fills the gap with regard to uterine polyp, cervicitis, cervical erosion, and vaginitis and vulvitis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The Oxford-FPA study includes 17 032 married women recruited at ages 25\u201339 years between 1968 and 1974 from clinics in England and Scotland. These women were followed up until mid-1994. Information collected during follow-up included details of contraceptive use, cervical smears taken at the clinic, pregnancies and hospital referrals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Oral contraceptive (OC) use was associated with a reduction in first hospital referral for uterine polyp and for vaginitis and vulvitis, which became more marked with increasing duration of use. There was a slightly increased rate of hospital referral for cervicitis in OC users. Referral for cervical erosion was markedly increased in current and recent OC users (rate ratio 2.1, 95% confidence interval 1.8\u20132.4). This increase in risk steadily declined after OC use was discontinued. First hospital referral for both uterine polyp and cervical erosion showed a highly significant negative association with numbers of cigarettes smoked per day. The explanation for these observations is unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>It should be remembered that the OCs studied were mainly those used in the 1970s and 1980s and mostly contained 50 \u03bcg estrogen. On balance, the overall effect of OC use on the conditions considered was neutral or beneficial. The apparent protective effect of cigarette smoking against uterine polyp and cervical erosion, even if valid, counts as nothing against the overwhelming adverse effects of smoking on health.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1783\/147118909787931988","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T19:14:01Z","timestamp":1239045241000},"page":"105-110","source":"Crossref","is-referenced-by-count":1,"title":["Some minor female reproductive system disorders: findings in the Oxford-Family Planning Association contraceptive study"],"prefix":"10.1136","volume":"35","author":[{"given":"Martin","family":"Vessey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Yeates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1017\/S0021932000010890","article-title":"A long-term follow-up study of women using different methods of contraception \u2013 an interim report","volume":"8","author":"Vessey, M.P.; Doll, R.; Peto, R.; Johnson, B.; Wiggins, P.","year":"1976","unstructured":"Vessey MP, Doll R, Peto R, Johnson B, Wiggins P. A long-term follow-up study of women using different methods of contraception \u2013 an interim report. J Biosoc Sci 1976; 8: 373\u2013425.","journal-title":"J Biosoc Sci"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/bjc.1996.247","article-title":"Oral contraceptives and cervical cancer \u2013 further findings from the Oxford-Family Planning Association contraceptive study","volume":"73","author":"Zondervan, K.T.; Carpenter, L.M.; Painter, R.; Vessey, M.P.","year":"1996","unstructured":"Zondervan KT, Carpenter LM, Painter R, Vessey MP. Oral contraceptives and cervical cancer \u2013 further findings from the Oxford-Family Planning Association contraceptive study. Br J Cancer 1996; 73: 1291\u20131297.","journal-title":"Br J Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer. Findings in a large cohort study","volume":"95","author":"Vessey, M.; Painter, R.","year":"2006","unstructured":"Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort study. Br J Cancer 2006; 95: 385\u2013389.","journal-title":"Br J Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bjc.1995.260","article-title":"Endometrial and ovarian cancer and oral contraceptives \u2013 findings in a large cohort study","volume":"71","author":"Vessey, M.P.; Painter, R.","year":"1995","unstructured":"Vessey MP, Painter R. Endometrial and ovarian cancer and oral contraceptives \u2013 findings in a large cohort study. Br J Cancer 1995; 71: 1340\u20131342.","journal-title":"Br J Cancer"},{"key":"ref_5","first-page":"120","article-title":"Return of fertility after discontinuation of oral contraceptives: influence of age and parity","volume":"11","author":"Vessey, M.P.; Smith, M.A.; Yeates, D.","year":"1986","unstructured":"Vessey MP, Smith MA, Yeates D. Return of fertility after discontinuation of oral contraceptives: influence of age and parity. Br J Fam Plann 1986; 11: 120\u2013124.","journal-title":"Br J Fam Plann"},{"key":"ref_6","first-page":"783","article-title":"Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use","volume":"97","author":"Buchan, H.; Villard-Mackintosh, L.; Vessey, M.P.; Yeates, D.; McPherson, K.","year":"1990","unstructured":"Buchan H, Villard-Mackintosh L, Vessey MP, Yeates D, McPherson K. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use. Br J Obstet Gynaecol 1990; 97: 783\u2013788.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/bmj.293.6543.359","article-title":"Risk factors for uterine fibroids: reduced risk associated with oral contraceptives","volume":"293","author":"Ross, R.K.; Pike, M.C.; Vessey, M.P.; Bull, D.; Yeates, D.; Casagrande, J.T.","year":"1986","unstructured":"Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. BMJ 1986; 293: 359\u2013362.","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/bmj.306.6871.182","article-title":"Epidemiology of endometriosis in women attending family planning clinics","volume":"306","author":"Vessey, M.P.; Villard-Mackintosh, L.; Painter, R.","year":"1993","unstructured":"Vessey MP, Villard-Mackintosh L, Painter R. Epidemiology of endometriosis in women attending family planning clinics. BMJ 1993; 306: 182\u2013184.","journal-title":"BMJ"},{"key":"ref_9","first-page":"166","article-title":"Oral contraception and other factors in relation to hospital referral for menstrual problems without known underlying cause: findings in a large cohort study","volume":"22","author":"Vessey, M.; Painter, R.; Mant, J.","year":"1997","unstructured":"Vessey M, Painter R, Mant J. Oral contraception and other factors in relation to hospital referral for menstrual problems without known underlying cause: findings in a large cohort study. Br J Fam Plann 1997; 22: 166\u2013169.","journal-title":"Br J Fam Plann"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1471-0528.1997.tb11536.x","article-title":"Epidemiology of genital prolapse: observations from the Oxford-Family Planning Association study","volume":"104","author":"Mant, J.; Painter, R.; Vessey, M.","year":"1997","unstructured":"Mant J, Painter R, Vessey M. Epidemiology of genital prolapse: observations from the Oxford-Family Planning Association study. Br J Obstet Gynaecol 1997; 104: 579\u2013585.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(03)13907-4","article-title":"Mortality in relation to oral contraceptive use and cigarette smoking","volume":"362","author":"Vessey, M.; Painter, R.; Yeates, D.","year":"2003","unstructured":"Vessey M, Painter R, Yeates D. Mortality in relation to oral contraceptive use and cigarette smoking. Lancet 2003; 362: 185\u2013191.","journal-title":"Lancet"},{"key":"ref_12","article-title":"Statistical Methods in Cancer Research. Vol. 2: The Design and Analysis of Cohort Studies (IARC","volume":"82","author":"Breslow, N.E.; Day, N.E.","year":"1987","unstructured":"Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol. 2: The Design and Analysis of Cohort Studies (IARC Scientific Publications No. 82). Lyon, France: International Agency for Cancer Research, 1987.","journal-title":"Scientific Publications"},{"key":"ref_13","first-page":"26","article-title":"30th anniversary of the Oxford-FPA contraceptive study","volume":"3","author":"Vessey, M.P.","year":"1998","unstructured":"Vessey MP. 30th anniversary of the Oxford-FPA contraceptive study. Trends in Urology, Gynaecology and Sexual Health 1998; 3: 26\u201333.","journal-title":"Trends in Urology, Gynaecology and Sexual Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM199608293350907","article-title":"Endometrial carcinoma","volume":"335","author":"Rose, P.G.","year":"1996","unstructured":"Rose PG. Endometrial carcinoma. N Engl J Med 1996; 335: 640\u2013649.","journal-title":"N Engl J Med"},{"key":"ref_15","first-page":"133","article-title":"Risks and benefits of oral contraceptive pills. Best Pract Res Clin","volume":"16","author":"D\u2019Souza, R.E.; Guillebaud, J.","year":"2002","unstructured":"D\u2019Souza RE, Guillebaud J. Risks and benefits of oral contraceptive pills. Best Pract Res Clin Obstet Gynaecol 2002; 16: 133\u2013154.","journal-title":"Obstet Gynaecol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajog.2004.01.061","article-title":"Safety concerns and health benefits associated with oral contraception","volume":"190","author":"Burkman, R.; Schlesselman, J.J.; Zieman, M.","year":"2004","unstructured":"Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol 2004; 190: S5\u2013S22.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/humupd\/dmi019","article-title":"The ESHRE Capri Workshop Group. Noncontraceptive health benefits of combined oral contraception","volume":"11","year":"2005","unstructured":"The ESHRE Capri Workshop Group. Noncontraceptive health benefits of combined oral contraception. Hum Reprod Update 2005; 11: 513\u2013525.","journal-title":"Hum Reprod Update"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0002-9378(86)90594-6","article-title":"Bacterial flora of the cervix in women using different methods of contraception","volume":"154","author":"Haukkamaa, M.; Stranden, P.; Jousimies-Somer, H.; Siitonen, A.","year":"1986","unstructured":"Haukkamaa M, Stranden P, Jousimies-Somer H, Siitonen A. Bacterial flora of the cervix in women using different methods of contraception. Am J Obstet Gynecol 1986; 154: 520\u2013524.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0002-9378(86)90601-0","article-title":"Etiology of cervical inflammation","volume":"154","author":"Paavonen, J.; Critchlow, C.W.; DeRouen, T.; Stevens, C.E.; Kiviat, N.; Brunham, R.C.","year":"1986","unstructured":"Paavonen J, Critchlow CW, DeRouen T, Stevens CE, Kiviat N, Brunham RC, et al. Etiology of cervical inflammation. Am J Obstet Gynecol 1986; 154: 556\u2013564.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0002-9378(95)90279-1","article-title":"Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking and douching","volume":"173","author":"Critchlow, C.W.; Wolner-Hansen, P.; Eschenbach, D.A.; Kiviat, N.B.; Koutsky, L.A.; Stevens, C.E.","year":"1995","unstructured":"Critchlow CW, Wolner-Hansen P, Eschenbach DA, Kiviat NB, Koutsky LA, Stevens CE, et al. Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking and douching. Am J Obstet Gynecol 1995; 173: 534\u2013543.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1010935723248","article-title":"Risk factors for and relationship between bacterial vaginosis and cervicitis in a high risk population for cervicitis in","volume":"17","author":"Keshavarz, H.; Duffy, S.W.; Sadeghi-Hassanabadi, A.; Zolghadr, Z.; Oboodi, B.","year":"2001","unstructured":"Keshavarz H, Duffy SW, Sadeghi-Hassanabadi A, Zolghadr Z, Oboodi B. Risk factors for and relationship between bacterial vaginosis and cervicitis in a high risk population for cervicitis in Southern Iran. Eur J Epidemiol 2001; 17: 89\u201395.","journal-title":"Southern Iran. Eur J Epidemiol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bmj.1.6115.748","article-title":"Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic","volume":"1","author":"Goldacre, M.J.; Loudon, N.; Watt, B.; Grant, G.; Loudon, J.D.O.; McPherson, K.","year":"1978","unstructured":"Goldacre MJ, Loudon N, Watt B, Grant G, Loudon JDO, McPherson K, et al. Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. BMJ 1978; 1: 748\u2013750.","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0002-9378(85)80105-8","article-title":"Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy and cervicitis","volume":"153","author":"Harrison, R.H.; Costin, M.; Meder, J.B.; Bownds, L.M.; Sim, D.A.; Lewis, M.","year":"1985","unstructured":"Harrison RH, Costin M, Meder JB, Bownds LM, Sim DA, Lewis M, et al. Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy and cervicitis. Am J Obstet Gynecol 1985; 153: 244\u2013251.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_24","first-page":"166","article-title":"The relation between cervical lesions and contraception method, smoking, parity, age and HRT","volume":"19","author":"Ozbay, K.; Yardim, T.","year":"2005","unstructured":"Ozbay K, Yardim T. The relation between cervical lesions and contraception method, smoking, parity, age and HRT. Jinekoloji ve Obstetrik Dergisi 2005; 19: 166\u2013170."},{"issue":"34","key":"ref_25","first-page":"373","article-title":"Oral contraceptive medications and vulvovaginal candidiasis","volume":"1969","author":"Diddle, A.W.; Gardner, W.H.; Williamson, P.J.; O\u2019Connor, K.A.","unstructured":"Diddle AW, Gardner WH, Williamson PJ, O\u2019Connor KA. Oral contraceptive medications and vulvovaginal candidiasis. Obstet Gynecol 1969; 34: 373\u2013377.","journal-title":"Obstet Gynecol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00016347009157254","article-title":"Incidence of Candida albicans in women using oral contraceptives","volume":"49","author":"Jensen, H.K.; Hansen, P.A.; Blom, J.","year":"1970","unstructured":"Jensen HK, Hansen PA, Blom J. Incidence of Candida albicans in women using oral contraceptives. Acta Obstet Gynecol Scand 1970; 49: 293\u2013296.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-0528.1985.tb04873.x","article-title":"The pill does not cause \u201cthrush\u201d","volume":"92","author":"Davidson, F.; Oates, J.K.","year":"1985","unstructured":"Davidson F, Oates JK. The pill does not cause \u201cthrush\u201d. Br J Obstet Gynecol 1985; 92: 1265\u20131266.","journal-title":"Br J Obstet Gynecol"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0002-9378(90)91186-G","article-title":"A follow-up study of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis","volume":"163","author":"Barbone, F.; Austin, H.; Louv, W.C.; Alexander, W.J.","year":"1990","unstructured":"Barbone F, Austin H, Louv WC, Alexander WJ. A follow-up study of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol 1990; 163: 510\u2013514.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1471-0528.1981.tb01213.x","article-title":"Prevalence of bacteria in the vagina of normal young women","volume":"88","author":"Watt, B.; Goldacre, M.J.; Loudon, N.; Annat, D.J.; Harris, R.I.; Vessey, M.P.","year":"1981","unstructured":"Watt B, Goldacre MJ, Loudon N, Annat DJ, Harris RI, Vessey MP. Prevalence of bacteria in the vagina of normal young women. Br J Obstet Gynecol 1981; 88: 588\u2013595.","journal-title":"Br J Obstet Gynecol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0010-7824(00)00155-4","article-title":"Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium","volume":"62","author":"Eschenbach, D.A.; Patton, D.L.; Meier, A.; Thwin, S.S.; Aura, J.; Stapleton, A.","year":"2000","unstructured":"Eschenbach DA, Patton DL, Meier A, Thwin SS, Aura J, Stapleton A, et al. Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium. Contraception 2000; 62: 107\u2013112.","journal-title":"Contraception"},{"key":"ref_31","first-page":"727","article-title":"Effects of intrauterine device and oral contraceptive on vaginal flora and epithelium","volume":"28","author":"Ocak, S.; Cetin, M.; Hakverdi, S.; Dolapcioglu, K.; Gungoren, A.; Hakverdi, A.U.","year":"2007","unstructured":"Ocak S, Cetin M, Hakverdi S, Dolapcioglu K, Gungoren A, Hakverdi AU. Effects of intrauterine device and oral contraceptive on vaginal flora and epithelium. Saudi Med J 2007; 28: 727\u2013731.","journal-title":"Saudi Med J"},{"key":"ref_32","first-page":"410","article-title":"Risk factors for bacterial vaginosis in women attending a hospital in Kerman, Islamic Republic of Iran","volume":"11","author":"Shraf-Ganjoei, T.","year":"2005","unstructured":"Shraf-Ganjoei T. Risk factors for bacterial vaginosis in women attending a hospital in Kerman, Islamic Republic of Iran. Eastern Mediterr Health J 2005; 11: 410\u2013415.","journal-title":"Eastern Mediterr Health J"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/sti.2003.004978","article-title":"Social and sexual risk factors for bacterial vaginosis","volume":"80","author":"Smart, S.; Singal, A.; Mindel, A.","year":"2004","unstructured":"Smart S, Singal A, Mindel A. Social and sexual risk factors for bacterial vaginosis. Sex Transm Infect 2004; 80: 58\u201362.","journal-title":"Sex Transm Infect"},{"key":"ref_34","article-title":"A unit funded by the FSRH and supported by NHS Greater Glasgow & Clyde to provide guidance on evidence-based practice","year":"2009","unstructured":"A unit funded by the FSRH and supported by NHS Greater Glasgow & Clyde to provide guidance on evidence-based practice New Product Review (March 2009)","journal-title":"New Product Review"},{"key":"ref_35","unstructured":"The Clinical Effectiveness Unit has produced a review of NuvaRing\u00ae, the combined vaginal ring now licensed for use in the UK. The document is freely available for download from the FSRH website \u2013 see New Product Reviews section (www.fsrh.org\/Default2.asp?Section=Publications &SubSection=ClinicalGuidance2).","article-title":"The Clinical Effectiveness Unit has produced a review of NuvaRing\u00ae, the combined vaginal ring now licensed for use in the UK"}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1783\/147118909787931988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:56:27Z","timestamp":1757098587000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1783\/147118909787931988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,4,1]]},"published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1783\/147118909787931988"],"URL":"https:\/\/doi.org\/10.1783\/147118909787931988","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"type":"print","value":"1471-1893"},{"type":"electronic","value":"2045-2098"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}